Literature DB >> 2473891

Purified preparations of the amniotic fluid-derived insulin-like growth factor-binding protein contain multimeric forms that are biologically active.

W H Busby1, P Hossenlopp, M Binoux, D R Clemmons.   

Abstract

The insulin-like growth factors (IGFs) appear to be secreted into interstitial fluids by many cell types, along with specific, high affinity binding proteins (IGF-BPs). These proteins, therefore, have the potential to bind IGF-I and -II and modify their ability to interact with specific cell surface receptors In these studies we report the detection of high mol wt, multimeric forms of one form of IGF-BP that has been purified from human amniotic fluid. The multimeric forms, which are either not or barely detectable in native amniotic fluid, are the result of intermolecular disulfide bond formation and can be reduced to a monomeric form by exposure to dithiothreitol. After reduction, the multimers are reduced to either monomeric or dimeric forms, as detected by Western blotting. The multimers can be separated from monomeric and dimeric forms by gel filtration chromatography. The purified multimers were fully biologically active in potentiating the effect of IGF-I on porcine aortic smooth muscle cell DNA synthesis. The monomeric form was also bioactive. No significant differences in the affinity of the monomeric and multimeric forms for IGF-I or -II could be detected. In summary, multimeric forms of this form of IGF-BP are detected during purification. The formation of these multimers is through intermolecular disulfide bonds and does not disrupt IGF binding or potentiation of the cellular growth response to IGF-I. These findings indicate that these higher mol wt forms may be fully active in biological test systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473891     DOI: 10.1210/endo-125-2-773

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

Review 1.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

2.  Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.

Authors:  Y Oh; M W Beukers; H M Pham; P A Smanik; M C Smith; R G Rosenfeld
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

3.  Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I.

Authors:  J I Jones; A J D'Ercole; C Camacho-Hubner; D R Clemmons
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

4.  Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry.

Authors:  Emmanuel Bujold; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Francesca Gotsch; Tinnakorn Chaiworapongsa; Ricardo Gomez; Jimmy Espinoza; Edi Vaisbuch; Yeon Mee Kim; Samuel Edwin; Mike Pisano; Beth Allen; Vladimir N Podust; Enrique A Dalmasso; Jennifer Rutherford; Wade Rogers; Allan Moser; Bo Hyun Yoon; Tim Barder
Journal:  J Matern Fetal Neonatal Med       Date:  2008-10

5.  Functional and complementary phosphorylation state attributes of human insulin-like growth factor-binding protein-1 (IGFBP-1) isoforms resolved by free flow electrophoresis.

Authors:  Mikkel Nissum; Majida Abu Shehab; Ute Sukop; Javad M Khosravi; Robert Wildgruber; Christoph Eckerskorn; Victor K M Han; Madhulika B Gupta
Journal:  Mol Cell Proteomics       Date:  2009-02-03       Impact factor: 5.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.